Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001019687-03-000413
Filing Date
2003-03-04
Accepted
2003-03-04 12:54:32
Documents
1
Period of Report
2003-03-01

Document Format Files

Seq Description Document Type Size
1 allen_f4-030103.txt 4 12231
  Complete submission text file 0001019687-03-000413.txt   14082
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-13341 | Film No.: 03590854
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TITAN PHARMACEUTICALS INC 400 OYSTER POINT BLVD S SAN FRANCISCO CA 94080
Business Address
ALLEN RICHARD C (Reporting) CIK: 0001180757 (see all company filings)